Choose Your Country or Region

HIV Protease

Choose Selective HIV Protease Inhibitors

HIV Protease Signaling Pathway Map

HIV Protease Products

All (19)
HIV Protease Inhibitors (19)
New HIV Protease Products

Catalog No.	Product Name	Information	Product Use Citations
S1030	Panobinostat (LBH589)	Panobinostat (LBH589, NVP-LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM in a cell-free assay. Panobinostat (LBH589) induces autophagy and apoptosis. Panobinostat effectively disrupts HIV latency in vivo. Phase 3.	Signal Transduct Target Ther, 2022, 7(1):98 Blood, 2022, blood.2022016241 Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7
S1185	Ritonavir (ABT-538)	Ritonavir (ABT-538, A 84538, RTV, Norvir, Norvir Softgel) is a Cytochrome P450 3A and Protease Inhibitor; Also inhibits Cytochrome P450 2D6, P-Glycoprotein and induces Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6 and UDP Glucuronosyltransferases. Ritonavir induces apoptosis.	Arch Toxicol, 2022, 96(7):2113-2122 Commun Biol, 2022, 5(1):154 J Virol, 2022, JVI0173021
S1380	Lopinavir (ABT-378)	Lopinavir (ABT-378) is a potent HIV protease inhibitor with K_i of 1.3 pM in a cell-free assay.	Pharmaceutics, 2022, 14(2)376 Commun Biol, 2022, 5(1):154 J Cell Biochem, 2022, 10.1002/jcb.30213
S1457	Atazanavir (BMS-232632) Sulfate	Atazanavir Sulfate (BMS-232632) is a HIV protease inhibitor with K_i of 2.66 nM in a cell-free assay.	Hum Cell, 2022, 10.1007/s13577-022-00671-y Sci Rep, 2021, 11(1):19443 Front Cardiovasc Med, 2021, 8:634774
S1620	Darunavir Ethanolate	Darunavir Ethanolate (TMC-114, UIC 94017) is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.	J Virol, 2022, JVI0173021 J Cell Biochem, 2022, 10.1002/jcb.30213 Sci Rep, 2021, 11(1):19443
S1639	Amprenavir (VX-478)	Amprenavir (VX-478, 141W94, KVX-478) is a potent PXR-selective agonist, and an HIV protease inhibitor, used to treat HIV.	Sci Rep, 2021, 11(1):19443 Antimicrob Agents Chemother, 2020, AAC.00872-20
S2319	Limonin	Limonin is a triterpenoid enriched in citrus fruits, which has antivirus and antitumor ability.	Int J Biol Sci, 2019, 15(11):2497-2508 Food Chem Toxicol, 2019, 125:621-628 Biomed Pharmacother, 2019, 118:109366
S3287	Rosamultin	Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina L. that inhibits HIV-1 protease. Rosamultin has protective effects on H₂O₂-induced oxidative damage and apoptosis.
S4282	Nelfinavir (AG 1343) Mesylate	Nelfinavir Mesylate (Viracept, AG1343) is a potent HIV protease inhibitor with K_i of 2 nM.	mBio, 2022, 13(1):e0304421 J Cell Biochem, 2022, 10.1002/jcb.30213 Cell Rep, 2021, 35(10):109218
S4662	Atazanavir	Atazanavir (Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents. Atazanavir is a substrate and inhibitor of cytochrome P450 isozyme 3A (CYP3A4) and an inhibitor and inducer of P-glycoprotein.	Sci Rep, 2021, 11(1):19443 Front Cardiovasc Med, 2021, 8:634774 ACS Infect Dis, 2020, 10.1021/acsinfecdis.0c00536
S5250	Darunavir	Darunavir (TMC114) is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.	J Cell Biochem, 2022, 10.1002/jcb.30213 Sci Rep, 2021, 11(1):19443 ACS Infect Dis, 2020, 10.1021/acsinfecdis.0c00536
S6581	Fosamprenavir calcium salt	Fosamprenavir is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. It is used for the treatment of HIV-1 infections.	Antimicrob Agents Chemother, 2020, AAC.00872-20
S6625	Temsavir (BMS-626529)	Temsavir (BMS-626529) is a novel small-molecule HIV-1 attachment inhibitor active against both CCR5- and CXCR4-tropic viruses.
S6929	Dextran sulfate sodium (DSS)	Dextran sulfate sodium (DSS) is a potent and selective inhibitor of human immunodeficiency virus type 1 (HIV-1) in vitro that inhibits virus adsorption to the host cells.
S6999	Chloroquine (NSC-187208)	Chloroquine (NSC-187208, Aralen, CHQ, CQ) is an antimalarial drug and autophagy/lysosome inhibitor. Chloroquine also suppresses Toll-like receptor-9 (TLR9) protein expression. Chloroquine is highly effective agianst SARS-CoV-2 (COVID-19) infection with EC50 of 1.13 μM in Vero E6 cells. Chloroquine has anti-HIV-1 activity.	Bioact Mater, 2022, 18:459-470 Redox Biol, 2022, 52:102292 Cell Death Dis, 2022, 13(2):150
S7381	Pepstatin A	Pepstatin A (Pepstatin) is a potent aspartic protease inhibitor, and also inhibits HIV replication. Pepstatin A is also an inhibitor of cathepsins D and cathepsins E. Pepstatin A inhibits autophagy by suppressing lysosomal proteases.	J Immunother Cancer, 2022, 10(3)e004129 PLoS Pathog, 2022, 18(1):e1010204 Pharmacol Res, 2021, S1043-6618(21)00517-X
S9010	Bevirimat	Bevirimat (MPC-4326, PA-457, YK-FH312), the prototype Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor, is highly potent in cell culture and efficacious in HIV-1 infected patients.
S9567	Indinavir Sulfate	Indinavir sulfate (Crixivan, L-735524, MK-639) is a specific and potent inhibitor of HIV-1 protease and is widely used in the treatment of AIDS.	J Cell Biochem, 2022, 10.1002/jcb.30213 Mol Metab, 2020, 29;101027 Antimicrob Agents Chemother, 2020, AAC.00872-20
S9625^New	Saquinavir (Ro 31-8959)	Saquinavir (Ro 31-8959) is a potent and selective inhibitor of HIV proteinase with a mean IC50 of 2.7 nM in JM cells.
S1030	Panobinostat (LBH589)	Panobinostat (LBH589, NVP-LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM in a cell-free assay. Panobinostat (LBH589) induces autophagy and apoptosis. Panobinostat effectively disrupts HIV latency in vivo. Phase 3.	Signal Transduct Target Ther, 2022, 7(1):98 Blood, 2022, blood.2022016241 Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7
S1185	Ritonavir (ABT-538)	Ritonavir (ABT-538, A 84538, RTV, Norvir, Norvir Softgel) is a Cytochrome P450 3A and Protease Inhibitor; Also inhibits Cytochrome P450 2D6, P-Glycoprotein and induces Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6 and UDP Glucuronosyltransferases. Ritonavir induces apoptosis.	Arch Toxicol, 2022, 96(7):2113-2122 Commun Biol, 2022, 5(1):154 J Virol, 2022, JVI0173021
S1380	Lopinavir (ABT-378)	Lopinavir (ABT-378) is a potent HIV protease inhibitor with K_i of 1.3 pM in a cell-free assay.	Pharmaceutics, 2022, 14(2)376 Commun Biol, 2022, 5(1):154 J Cell Biochem, 2022, 10.1002/jcb.30213
S1457	Atazanavir (BMS-232632) Sulfate	Atazanavir Sulfate (BMS-232632) is a HIV protease inhibitor with K_i of 2.66 nM in a cell-free assay.	Hum Cell, 2022, 10.1007/s13577-022-00671-y Sci Rep, 2021, 11(1):19443 Front Cardiovasc Med, 2021, 8:634774
S1620	Darunavir Ethanolate	Darunavir Ethanolate (TMC-114, UIC 94017) is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.	J Virol, 2022, JVI0173021 J Cell Biochem, 2022, 10.1002/jcb.30213 Sci Rep, 2021, 11(1):19443
S1639	Amprenavir (VX-478)	Amprenavir (VX-478, 141W94, KVX-478) is a potent PXR-selective agonist, and an HIV protease inhibitor, used to treat HIV.	Sci Rep, 2021, 11(1):19443 Antimicrob Agents Chemother, 2020, AAC.00872-20
S2319	Limonin	Limonin is a triterpenoid enriched in citrus fruits, which has antivirus and antitumor ability.	Int J Biol Sci, 2019, 15(11):2497-2508 Food Chem Toxicol, 2019, 125:621-628 Biomed Pharmacother, 2019, 118:109366
S3287	Rosamultin	Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina L. that inhibits HIV-1 protease. Rosamultin has protective effects on H₂O₂-induced oxidative damage and apoptosis.
S4282	Nelfinavir (AG 1343) Mesylate	Nelfinavir Mesylate (Viracept, AG1343) is a potent HIV protease inhibitor with K_i of 2 nM.	mBio, 2022, 13(1):e0304421 J Cell Biochem, 2022, 10.1002/jcb.30213 Cell Rep, 2021, 35(10):109218
S4662	Atazanavir	Atazanavir (Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents. Atazanavir is a substrate and inhibitor of cytochrome P450 isozyme 3A (CYP3A4) and an inhibitor and inducer of P-glycoprotein.	Sci Rep, 2021, 11(1):19443 Front Cardiovasc Med, 2021, 8:634774 ACS Infect Dis, 2020, 10.1021/acsinfecdis.0c00536
S5250	Darunavir	Darunavir (TMC114) is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.	J Cell Biochem, 2022, 10.1002/jcb.30213 Sci Rep, 2021, 11(1):19443 ACS Infect Dis, 2020, 10.1021/acsinfecdis.0c00536
S6581	Fosamprenavir calcium salt	Fosamprenavir is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. It is used for the treatment of HIV-1 infections.	Antimicrob Agents Chemother, 2020, AAC.00872-20
S6625	Temsavir (BMS-626529)	Temsavir (BMS-626529) is a novel small-molecule HIV-1 attachment inhibitor active against both CCR5- and CXCR4-tropic viruses.
S6929	Dextran sulfate sodium (DSS)	Dextran sulfate sodium (DSS) is a potent and selective inhibitor of human immunodeficiency virus type 1 (HIV-1) in vitro that inhibits virus adsorption to the host cells.
S6999	Chloroquine (NSC-187208)	Chloroquine (NSC-187208, Aralen, CHQ, CQ) is an antimalarial drug and autophagy/lysosome inhibitor. Chloroquine also suppresses Toll-like receptor-9 (TLR9) protein expression. Chloroquine is highly effective agianst SARS-CoV-2 (COVID-19) infection with EC50 of 1.13 μM in Vero E6 cells. Chloroquine has anti-HIV-1 activity.	Bioact Mater, 2022, 18:459-470 Redox Biol, 2022, 52:102292 Cell Death Dis, 2022, 13(2):150
S7381	Pepstatin A	Pepstatin A (Pepstatin) is a potent aspartic protease inhibitor, and also inhibits HIV replication. Pepstatin A is also an inhibitor of cathepsins D and cathepsins E. Pepstatin A inhibits autophagy by suppressing lysosomal proteases.	J Immunother Cancer, 2022, 10(3)e004129 PLoS Pathog, 2022, 18(1):e1010204 Pharmacol Res, 2021, S1043-6618(21)00517-X
S9010	Bevirimat	Bevirimat (MPC-4326, PA-457, YK-FH312), the prototype Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor, is highly potent in cell culture and efficacious in HIV-1 infected patients.
S9567	Indinavir Sulfate	Indinavir sulfate (Crixivan, L-735524, MK-639) is a specific and potent inhibitor of HIV-1 protease and is widely used in the treatment of AIDS.	J Cell Biochem, 2022, 10.1002/jcb.30213 Mol Metab, 2020, 29;101027 Antimicrob Agents Chemother, 2020, AAC.00872-20
S9625^New	Saquinavir (Ro 31-8959)	Saquinavir (Ro 31-8959) is a potent and selective inhibitor of HIV proteinase with a mean IC50 of 2.7 nM in JM cells.
S9625^New	Saquinavir (Ro 31-8959)	Saquinavir (Ro 31-8959) is a potent and selective inhibitor of HIV proteinase with a mean IC50 of 2.7 nM in JM cells.